 Taysha Gene Therapies, Inc. NASDAQ:TSHA Q3 2022 Results Earnings Conference Call November 8, 2022 8:00 AM ET Company Participants Kimberly Lee - Chief Corporate Affairs Officer RA Session - President, Founder and Chief Executive Officer Suyash Prasad - Chief Medical Officer and Head of Research and Development Kamran Alam - Chief Financial Officer Fred Porter - Chief Technical Officer Conference Call Participants Gil Blum - Needham Company, LLC Geulah Livshits - Chardan Mehdi Goudarzi - Truist Securities Michael Ulz - Morgan Stanley David Hoang - SMBC Nikko Benjamin Paluch - Robert W. Baird Yanan Zhu - Wells Fargo Tiffany Marchell - William Blair Whitney Ijem - Canaccord Genuity Operator Thank you for standing by. 